Company Description
AlphaTON Capital Corp. operates as a digital asset treasury company.
It focuses on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem.
The company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.
Its activities cover network validation and staking operations, and development of Telegram-based applications, as well as strategic investments in TON-based decentralized finance protocols, gaming platforms, and business applications.
The company is also advancing various therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients.
The company was formerly known as Portage Biotech Inc. and changed its name to AlphaTON Capital Corp. in September 2025.
AlphaTON Capital Corp. is based in Road Town, British Virgin Islands.
| Country | British Virgin Islands |
| Founded | 1973 |
| Industry | Asset Management |
| Sector | Financials |
| Employees | 4 |
| CEO | Brittany Kaiser |
Contact Details
Address: Clarence Thomas Building, P.O. Box 4649 Road Town, VG1110 British Virgin Islands | |
| Phone | 302 219 5556 |
| Website | alphatoncapital.com |
Stock Details
| Ticker Symbol | ATON |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001095435 |
| CUSIP Number | G7185A136 |
| ISIN Number | VGG7185A1369 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Peter Molloy | Chief Executive Officer of Cyncado Therapeutics Inc. |
| Brittany Kaiser | Chief Executive Officer and Director |
| Dr. Robert A. Kramer Ph.D. | Chief Scientific Officer |
| Wesley Allen Levitt C.F.A., M.B.A. | Chief Financial Officer |
| William De'Ath | Chief Partnership Officer |
| Adam Melero | Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 3, 2025 | F-3 | Filing |
| Nov 26, 2025 | 6-K | Report of foreign issuer |
| Nov 26, 2025 | 424B5 | Filing |
| Nov 21, 2025 | 6-K | Report of foreign issuer |
| Nov 6, 2025 | F-3 | Filing |
| Nov 6, 2025 | F-3/A | Filing |
| Oct 23, 2025 | 424B3 | Prospectus |
| Oct 23, 2025 | 6-K | Report of foreign issuer |
| Oct 22, 2025 | 424B3 | Prospectus |
| Oct 22, 2025 | 6-K | Report of foreign issuer |